QUICK
MENU
Partners Media Releases Contact Us

About CUBEBIO

As a biomedical company dedicated to research and development of in vitro diagnostics for early cancer detection,
we will become the world's best company by contributing to the promotion of people's health and happiness.

history

Overview & History

Overviwe

NAME CUBEBIO Co., Ltd.
BUSINESS Research and development of medicine and pharmacy,
Distribution of drug medicines and medical devices
MAIN PRODUCTS Cancer Diagnostic Rapid Kit, ELISA Kit, Self-Diagnostic Device
ADDRESS 8F Shinhan Life Bldg, Digital-ro 10-gil 9, Geumcheon-gu, Seoul, Korea
CAPITAL 16 billion KRW (US$15 million)
R & D PRODUCTS Cancer Biomarker
Single- & multi-Cancer Biomarker
Specimen
Urine, Blood

History

2011

11 Established CUBEBIO Co., Ltd.

2014

10 Attracted investments worth 3 billion
KRW from Development Bank CB

2015

03 Certified as a company-affiliated
research center

04 Certified as a venture business

2016

05 Completed merging with CUBEBIO

2017

10 Gained the manufacturing approval
for medical devices
Earned the export approval for medical
devices (Korean Ministry of Food
and Drug Safety)

2018

12 Gained approval from the
FDA of the Philippines

2019

01 Awarded the Korean Patent Grand Prize 02 Obtained the approval for sales of Class II
in vitro diagnostics from the Chinese FDA
(沈阳阿一生物科技有限公司) Signed a contract with Yongchenghanyuan
(永成汉源), a China/Hong Kong-based
large asset management company,
with regards to investments and
Nasdaq listings
04 Signed a contract with Samsung
Securities Co., Ltd., as a lead underwriter 07 The signing of Patron partnership
agreement as well as 'CUBEBIO-UICC
Cancer Early Detection and Self-Diagnosis'
program agreement with the Union for
International Cancer Control (UICC) Awarded the 2019 Moneytoday Grand Prize
for Innovative Technology in the field of
innovative technology
'Cancer Self-Diagnostic Device'
09 Signed a contract for the export of
cancer self-diagnostic devices
in the Russian Federation and CIS countries .
Awarded the Global Top Technology
Grand Prize at the 2019 Moneytoday
World Class Small-Mighty Enterprise Award
10 Participation in the UICC-led
World Cancer Leaders' Summit in
Kazakhstan by invitation only